Amarin Corporation plc - Special Call Transcript
Welcome to Amarin Corporation's conference call to discuss select scientific publications from the American College of Cardiology's 69th Annual Scientific Session together with the World Congress of Cardiology. This conference call is being recorded today, March 30, 2020.
I will now turn the conference call over to Elisabeth Schwartz, Senior Director of Investor Relations of Amarin. Please go ahead.
Welcome to today's discussion with several distinguished invited guests to explore with our investment community the several important new data sets and analyses related to VASCEPA and REDUCE-IT presented to the medical community at the American College of Cardiology's 69th Annual Scientific Session together with World College of -- Congress of Cardiology. To level set expectations, we will be limiting this session to scientific matters directly presented during the recently completed ACC meeting. We'll not be discussing business matters, including Amarin's ANDA litigation or any matters
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |